In the present study, we aimed at exploring the spatial overlap of pre-defined functional brain networks and the extent of neurofibrillary tau pathology assessed with 18F-AV-1451 PET in prodromal and dementia stages of AD, also answering the question whether tau pathology preferrably affects the DMN over other ICNs. This evidence concerns the gene MAPT and Alzheimer disease.